Search research articles
Contact Us
Filters
Showing results (151-160 of 156) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 156 results.
Cell Chemical Biology
|
March 24, 2023
Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome
Ioanna Deni, Barbara H Stokes, Kurt E Ward, et al.
Nature Cancer
|
May 22, 2023
The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSCLC
Aaron Javitt, Merav D Shmueli, Matthias P Kramer, et al.
Science (New York, N.Y.)
|
September 22, 2001
Environment. Can we defy nature's end?
S L Pimm, M Ayres, A Balmford, et al.
European Heart Journal
|
May 11, 2024
Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trial
Pascal R D Clephas, Victor W Zwartkruis, Jishnu Malgie, et al.
European Journal of Heart Failure
|
June 3, 2024
Serial cardiac biomarkers, pulmonary artery pressures and traditional parameters of fluid status in relation to prognosis in patients with chronic heart failure: Design and rationale of the BioMEMS study
Youssra Allach, Mylene Barry-Loncq de Jong, Pascal R D Clephas, et al.
European Journal of Heart Failure
|
May 12, 2024
Contemporary guideline-directed medical therapy in de novo, chronic, and worsening heart failure patients: First data from the TITRATE-HF study
Jishnu Malgie, Mariëlle I Wilde, Pascal R D Clephas, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 156) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 156 results.
Cell Chemical Biology
|
March 24, 2023
Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome
Ioanna Deni, Barbara H Stokes, Kurt E Ward, et al.
Nature Cancer
|
May 22, 2023
The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSCLC
Aaron Javitt, Merav D Shmueli, Matthias P Kramer, et al.
Science (New York, N.Y.)
|
September 22, 2001
Environment. Can we defy nature's end?
S L Pimm, M Ayres, A Balmford, et al.
European Heart Journal
|
May 11, 2024
Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trial
Pascal R D Clephas, Victor W Zwartkruis, Jishnu Malgie, et al.
European Journal of Heart Failure
|
June 3, 2024
Serial cardiac biomarkers, pulmonary artery pressures and traditional parameters of fluid status in relation to prognosis in patients with chronic heart failure: Design and rationale of the BioMEMS study
Youssra Allach, Mylene Barry-Loncq de Jong, Pascal R D Clephas, et al.
European Journal of Heart Failure
|
May 12, 2024
Contemporary guideline-directed medical therapy in de novo, chronic, and worsening heart failure patients: First data from the TITRATE-HF study
Jishnu Malgie, Mariëlle I Wilde, Pascal R D Clephas, et al.
Page
of 16